Home » Additional Features

FDA to Hold Public Workshop to Discuss Biosimilar Product Development

1 September 2022 No Comment

The US Food and Drug Administration is hosting a one-day virtual public workshop called “Increasing the Efficiency of Biosimilar Development Programs” on September 19 from 9 a.m. to 4 p.m.

This public workshop will focus on statistical, scientific, and clinical methods for streamlining comparative clinical studies associated with biosimilar product development programs.

The workshop is open to the public; however, registration is required.

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Comments are closed.